(Q42445348)

31 October 2017

title

Losartan reverses glomerular podocytes injury induced by AngII via stabilizing the expression of GLUT1. (English)

1 reference

31 October 2017

1 reference

S Y Yu

1

1 reference

31 October 2017

R Qi

series ordinal

2

1 reference

31 October 2017

H Zhao

series ordinal

3

1 reference

31 October 2017

publication date

24 September 2013

1 reference

Molecular Biology Reports

31 October 2017

published in

1 reference

31 October 2017

volume

40

1 reference

31 October 2017

issue

11

1 reference

31 October 2017

page(s)

6295-6301

1 reference

https://scigraph.springernature.com/pub.10.1007/s11033-013-2742-9

31 October 2017

exact match

0 references

cites work

Podocyte loss and progressive glomerular injury in type II diabetes

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Combination ACEI and ARB therapy: additional benefit in renoprotection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Achieving maximal renal protection in nondiabetic chronic renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Clinical renoprotection trials involving angiotensin II-receptor antagonists and angiotensin-converting-enzyme inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

The hyperfiltration theory: a paradigm shift in nephrology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Role of bad in podocyte apoptosis induced by puromycin aminonucleoside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Crystal structure of a bacterial homologue of glucose transporters GLUT1-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Relationship between five GLUT1 gene single nucleotide polymorphisms and diabetic nephropathy: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11033-013-2742-9

Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats

21 January 2018

1 reference

12 December 2020

Effects of losartan on renal function in patients with essential hypertension

1 reference

12 December 2020

Hyperfiltration in remnant nephrons: a potentially adverse response to renal ablation

1 reference

12 December 2020

Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy

1 reference

12 December 2020

Mouse models of diabetic nephropathy

1 reference

12 December 2020

Expression of mediators of renal injury in the remnant kidney of ROP mice is attenuated by cyclooxygenase-2 inhibition

1 reference

12 December 2020

10.1007/S11033-013-2742-9

Identifiers

DOI

1 reference

31 October 2017

1 reference